Submission of outcome of the meeting of the board of directors held on Monday 19th May, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Astal Laboratories Ltd met on 19 May 2025 and approved the audited standalone financial results for Q4 and full year ended 31 March 2025. Full-year revenue from operations surged to Rs 6,423.10 lakhs from Rs 2,364.77 lakhs in the previous year, while net profit jumped sharply to Rs 892.53 lakhs from Rs 78.47 lakhs. Basic EPS for FY25 stood at Rs 9.08 compared to Rs 1.55 in FY24. Total assets grew to Rs 6,334.06 lakhs and total equity to Rs 3,599.47 lakhs. The statutory auditors issued an unmodified (clean) opinion. The board also re-appointed VRP S & Co. as internal auditors for FY26, appointed Mahendra Khandelwal & Co. as secretarial auditor for five years, and constituted a CSR committee with three directors.
Strong topline growth and a near 11x rise in full-year profit signal a major business turnaround, likely to be viewed positively by shareholders, though rising trade receivables and borrowing levels warrant attention.